Miris® receives US FDA De Novo clearance for the Miris® Human Milk Analyzer™   Miris® receives US FDA De Novo clearance for the Miris® Human Milk Analyzer™ View this email in your browser

Miris receives US FDA De Novo clearance for the Miris Human Milk Analyzer™ With the company’s De Novo request now granted, the Miris Human Milk Analyzer™ (HMA) is the only approved device for macronutrient analysis of human milk on the US market. Press announcement Miris HMA quantitatively measures the concentration of fat, carbohydrate and protein in human milk, and provides calculated values for total solids and energy. In conjunction with other clinical assessments, these measurements provide valuable knowledge for clinicians in the nutritional management of newborns, including preterm, and infants. Take nutritional management in your NICU to the next level by gaining data on the macronutrient content in mother’s own milk and in donated breast milk. Contact us to get your quote Bringing neonatal care to the world Swedish neonatal care ranks among the best in the world. More preterm babies grow up to become healthy kids in Sweden than in most other countries. Individualized nutrition through target fortification is one of the specific management routines used to ensure better recovery, growth, and cognitive outcome. Miris is proud to be part of this tradition, which is built on years of experience and dedication. Giving every premature infant the best possible start in life is what inspires us and keeps us committed. We want to share our knowledge and engagement with the rest of the world to enable improved neonatal health.

Miris® HMA™ Human Milk Analyser is cleared by FDA

FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk.